Lipid peroxidation product acrolein as a predictive biomarker of prostate carcinoma relapse after radical surgery

Free Radical Research

Volumn 44, Issue 5, 2010, Pages 497-504

  Custovic, Zajim ^a   Zarkovic, Kamelija ^b   Cindric, Marina ^b   Cipak, Ana ^c   Jurkovic, Ilija ^a   Sonicki, Zdenko ^b   Uchida, Koji ^d   Zarkovic, Neven ^c  

^a Dubrovnik General Hospital   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c RUDER BO KOVI INSTITUTE   (Croatia)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

4 hydroxynonenal; Acrolein; Immunohistochemistry; Lipid peroxidation; Oxidative stress; Prostate carcinogenesis; Reactive aldehydes

Indexed keywords

ACROLEIN; ALDEHYDE; BIOCHEMICAL MARKER; BIOLOGICAL MARKER; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER RELAPSE; CARCINOGENESIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVALUATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PREDICTION; PREDICTIVE VALIDITY; PROSTATE CARCINOMA; PROSTATECTOMY;

ACROLEIN; AGED; HUMANS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; RECURRENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 77951293458     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715761003636831     Document Type: Article

References (38)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer Statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Basu HS, Thompson TA, Church DR, Clower CC, Mehraein-Ghomi F, Amlong CA, Martin CT, Woster PM, Lindstrom MJ, Wilding G. Small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adeno-carcinoma of the mouse prostate model. Cancer Res 2009;69:7689-7695.
3. Khandrika L, Kumar B, Koul S, Maroni P, Koul HK. Oxidative stress and prostate cancer. Cancer Lett 2009;282:125-136.
4. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL. Effect of infl ammation and benign prostatic hyperplasia on elevated serum prostate specifi c antigen levels. J Urol 1995;154:407-413.
5. Serkova NJ, Gamito EJ, Jones RH, O'Donnell C, Brown JL, Green S, Sullivan H, Hedlund T, Crawford ED. The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions. Prostate 2008;68:620-628. (Pubitemid 351614640)
6. Dong JT, Rinker-Schaeffer CW, Ichikawa T, Barrett JC, Isaacs J T. Prostate cancer-biology of metastasis and its clinical implications. World J Urol 1996;14:182-189. (Pubitemid 126775160)
7. Carter HB, Piantadosi S, Isaacs J T. Clinical evidence for and implications of the multistep development of prostate cancer. J Urol 1990;143:742-746. (Pubitemid 20112094)
8. Pienta KJ, Esper PS. Risk factors for prostate cancer. Ann Int Med 1993;118:793-803.
9. Ripple MO, Henry WF, Rago RP, Wilding G. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells, J Natl Cancer Inst 1997;89:40-48. (Pubitemid 26428076)
10. Przybyszewski WM, Rzeszowska-Wolny J. Oxidative stress in prostate hypertrophy and carcinogenesis. Postepy Hig Med Dosw 2009;63:340-350.
11. Esterbauer H, Schaur JS, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic Biol Med 1991;11:81-128. (Pubitemid 121003917)
12. Einhorn IN. Physiological and toxicological aspects of smoke produced during the combustion of polymeric materials. Environ Health Perspect 1975;11:163-189.
13. Johnstone RAW, Plimmer JR. The chemical constituents of tobacco and tobacco smoke. Chem Rev 1959;59:885-936.
14. Izard C, Libermann C. Acrolein. Mutat Res 1978;47:115-138.
15. Anderson MM, Hazen SL, Hsu FF, Heinecke JW. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycola-ldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of infl ammation. J Clin Invest 1997;99:424-432.
16. Beauchamp RO Jr, Andjelkovich DA, Kligerman AD, Morgan KT, Heck HD. A critical review of the literature on acrolein toxicity. Crit Rev Toxicol 1985;14:309-380. (Pubitemid 15037387)
17. Tabor CW, Tabor H, Bachrach U. Identifi cation of the ami-noaldehydes produced by the oxidation of spermine and sper-midine with purifi ed plasma amine oxidase. J Biol Chem 1964;239:2194-2203.
18. Rudra PK, Krokan HE. Acrolein cytotoxicity and glutathione depletion in n-3 fatty acid sensitive-and resistant human tumor cells. Anticancer Res 1999;19:461-469.
19. Zarkovic K, Uchida K, Kolenc D, Hlupic L, Zarkovic N Tissue distribution of lipid peroxidation product acrolein in human colon carcinogenesis. Free Radic Res 2006;40:543-552. (Pubitemid 43832508)
20. Uchida K, Kanematsu M, Sakai K, Matsuda T, Hattori N, Mizuno Y, Suzuki D, Miyata T, Noguchi N, Niki E, Osawa T. Protein-bound acrolein: Potential markers for oxidative stress (covalent modifi cation of protein/antibody/ atherosclerosis). Proc Natl Acad Sci USA Biochem 1998;95:4882-4887.
21. Yilmaz MI, Saglam K, Sonmez A, Gok DE, Basal S, Kilic S, Akay C, Kocar IH. Antioxidant system activation in prostate cancer. Biol Trace Elem Res 2004;98:13-19. (Pubitemid 38526629)
22. Zibzibadze M, Bochorishvili I, Ramishvili L, Managadze L, Kotrikadze N. Investigation of pro-and antioxidative systems' changes in blood of patients with prostate tumours. Georgian Med News 2009;169:26-29.
23. Iuchi Y, Kaneko T, Matsuki S, Ishi T, Ikeda Y, Uchida K, Fujii J. Carbonyl stress and detoxifi cation ability in the male genital tract and testis of rats. Histochem Cell Biol 2004;121:123-130. (Pubitemid 38316655)
24. Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK. Oxi-dative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 2008;68:1777-1785. (Pubitemid 351416563)
25. Yu YP, Yu G, Tseng G, Cieply K, Nelson J, Defrances M, Zarnegar R, Michalopoulos G, Luo JH. Glutathione peroxi-dase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res 2007; 67:8043-8050. (Pubitemid 47395138)
26. Sakata K, Kashiwagi K, Sharmin S, Ueda S, Igarashi K. Acrolein produced from polyamines as one of the uraemic toxins. Biochem Soc Trans 2003;31:371-374. (Pubitemid 36520679)
27. Goodwin AC, Jadallah S, Toubaji A, Lecksell K, Hicks JL, Kowalski J, Bova GS, De Marzo AM, Netto GJ, Casero RA Jr. Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues. Prostate 2008;68:766-772. (Pubitemid 351632948)
28. Babbar N, Casero RA Jr. Tumor necrosis factor-alpha increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: a potential mechanism for infl ammation induced carcinogenesis. Cancer Res 2006; 66:11125-11130. (Pubitemid 46009938)
29. Xu H, Chaturvedi R, Cheng Y, Bussiere FI, Asim M, Yao MD, Potosky D, Meltzer SJ, Rhee JG, Kim SS, Moss SF, Hacker A, Wang Y, Casero RA Jr, Wilson KT. Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res 2004;64:8521-8525. (Pubitemid 39552063)
30. Yelisyeyeva O, Cherkas A, Zarkovic K, Semen K, Kaminskyy D, Waeg G, Zarkovic N. The distribution of 4-hydroxynonenal-modifi ed proteins in gastric mucosa of duodenal peptic ulcer patients. Free Radic Res 2008;42:205-211. (Pubitemid 351419906)
31. Cherkas A, Yelisyeyeva O, Semen K, Zarkovic K, Kaminskyy D, Cipak A, Jaganjac M, Lutsyk A, Waeg G, Zarkovic N. Persistent accumulation of 4-hydroxynonenal-protein adducts in gastric mucosa after Helicobacter pylori eradication. Coll Antropol 2009;33:315-321.
32. Zarkovic N. 4-Hydroxynonenal as a bioactive marker of pathopysiological processes. Mol Asp Med 2003;24:281-291. (Pubitemid 36945028)
33. Zarkovic N, Ilic Z, Jurin M, Scahur RJ, Puhl H, Esterbauer H. Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochem Func 1993;11: 279-286. (Pubitemid 23342143)
34. Zarkovic N, Zarkovic K, Schaur RJ, Stolc S, Schlag G, Redl H, Waeg G, Borovic S, Loncaric I, Juric G, Hlavka V. 4-Hydroxynonenal as a second messenger of free radicals and growth modifying factor. Life Sci 1999;65:1901-1904. (Pubitemid 29506925)
35. Biasi F, Tessitore L, Zanetti D, Citrin JC, Zingaro B, Chiarpotto E, Zarkovic N, Serviddio G, Poli G. Associated changes of lipid peroxidation and TGF-β1 levels in human cancer during tumor progression. Gut 2002;50:361-367.
36. Biasi F, Vizio B, Mascia C, Gaia E, Zarkovic N, Chiarpotto E, Leonarduzzi G, Poli G. JNK up-regulation as a key event in the pro-apoptotic interaction between TGF-β1 and 4-hydrox-ynonenal in colon mucosa. Free Radic Biol Med 2006;40: 443-454.
37. Marquez-Quiñones A, Cipak A, Zarkovic K, Fattel-Fazenda S, Villa-Treviño S, Zarkovic N, Guéraud F. HNE-protein adducts formation in different pre-carcinogenic stages of hepatitis in LEC rats. Free Radic Res, 2010;44:119-127.
38. Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, Khachik F, Li YW, Banerjee M, Grignon D, Bertram JS, Crissman JD, Pontes EJ, Wood DP Jr. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 2001;10: 861-868. (Pubitemid 32738598)